Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Sep 2025 value amounting to -0.30%.

  • Arcturus Therapeutics Holdings' Return on Capital Employed fell 4.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year decrease of 4.00%. This contributed to the annual value of -0.30% for FY2024, which is 8.00% down from last year.
  • According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Return on Capital Employed is -0.30%, which was down 12.01% from -0.26% recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Return on Capital Employed registered a high of 0.21% during Q1 2023, and its lowest value of -0.75% during Q1 2022.
  • Over the past 3 years, Arcturus Therapeutics Holdings' median Return on Capital Employed value was -0.26% (recorded in 2025), while the average stood at -0.17%.
  • In the last 5 years, Arcturus Therapeutics Holdings' Return on Capital Employed surged by 96bps in 2023 and then crashed by 61bps in 2024.
  • Arcturus Therapeutics Holdings' Return on Capital Employed (Quarterly) stood at -0.65% in 2021, then spiked by 70bps to 0.05% in 2022, then declined by 27bps to -0.22% in 2023, then dropped by 11bps to -0.33% in 2024, then declined by 4bps to -0.30% in 2025.
  • Its Return on Capital Employed was -0.30% in Q3 2025, compared to -0.26% in Q2 2025 and -0.28% in Q1 2025.